Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method.

Flieswasser T, Camara-Clayette V, Danu A, Bosq J, Ribrag V, Zabrocki P, Van Rompaey L, de Haard H, Zwaenepoel K, Smits E, Pauwels P, Jacobs J.

Cancers (Basel). 2019 Oct 22;11(10). pii: E1611. doi: 10.3390/cancers11101611.

2.

The yeast protein kinase Sch9 adjusts V-ATPase assembly/disassembly to control pH homeostasis and longevity in response to glucose availability.

Wilms T, Swinnen E, Eskes E, Dolz-Edo L, Uwineza A, Van Essche R, Rosseels J, Zabrocki P, Cameroni E, Franssens V, De Virgilio C, Smits GJ, Winderickx J.

PLoS Genet. 2017 Jun 12;13(6):e1006835. doi: 10.1371/journal.pgen.1006835. eCollection 2017 Jun.

3.

Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment.

Lambertz I, Kumps C, Claeys S, Lindner S, Beckers A, Janssens E, Carter DR, Cazes A, Cheung BB, De Mariano M, De Bondt A, De Brouwer S, Delattre O, Gibbons J, Janoueix-Lerosey I, Laureys G, Liang C, Marchall GM, Porcu M, Takita J, Trujillo DC, Van Den Wyngaert I, Van Roy N, Van Goethem A, Van Maerken T, Zabrocki P, Cools J, Schulte JH, Vialard J, Speleman F, De Preter K.

Clin Cancer Res. 2015 Jul 15;21(14):3327-39. doi: 10.1158/1078-0432.CCR-14-2024. Epub 2015 Mar 24.

4.

FLT1 kinase is a mediator of radioresistance and survival in head and neck squamous cell carcinoma.

Van Limbergen EJ, Zabrocki P, Porcu M, Hauben E, Cools J, Nuyts S.

Acta Oncol. 2014 May;53(5):637-45. doi: 10.3109/0284186X.2013.835493. Epub 2013 Sep 16.

PMID:
24041258
5.

Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification.

De Brouwer S, De Preter K, Kumps C, Zabrocki P, Porcu M, Westerhout EM, Lakeman A, Vandesompele J, Hoebeeck J, Van Maerken T, De Paepe A, Laureys G, Schulte JH, Schramm A, Van Den Broecke C, Vermeulen J, Van Roy N, Beiske K, Renard M, Noguera R, Delattre O, Janoueix-Lerosey I, Kogner P, Martinsson T, Nakagawara A, Ohira M, Caron H, Eggert A, Cools J, Versteeg R, Speleman F.

Clin Cancer Res. 2010 Sep 1;16(17):4353-62. doi: 10.1158/1078-0432.CCR-09-2660. Epub 2010 Aug 18.

6.

Mitochondrial dysfunction leads to reduced chronological lifespan and increased apoptosis in yeast.

Aerts AM, Zabrocki P, Govaert G, Mathys J, Carmona-Gutierrez D, Madeo F, Winderickx J, Cammue BP, Thevissen K.

FEBS Lett. 2009 Jan 5;583(1):113-7. doi: 10.1016/j.febslet.2008.11.028. Epub 2008 Dec 4.

7.

Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson.

Zabrocki P, Bastiaens I, Delay C, Bammens T, Ghillebert R, Pellens K, De Virgilio C, Van Leuven F, Winderickx J.

Biochim Biophys Acta. 2008 Oct;1783(10):1767-80. doi: 10.1016/j.bbamcr.2008.06.010. Epub 2008 Jun 19.

8.

Ydc1p ceramidase triggers organelle fragmentation, apoptosis and accelerated ageing in yeast.

Aerts AM, Zabrocki P, François IE, Carmona-Gutierrez D, Govaert G, Mao C, Smets B, Madeo F, Winderickx J, Cammue BP, Thevissen K.

Cell Mol Life Sci. 2008 Jun;65(12):1933-42. doi: 10.1007/s00018-008-8129-8.

PMID:
18500447
9.

Protein folding diseases and neurodegeneration: lessons learned from yeast.

Winderickx J, Delay C, De Vos A, Klinger H, Pellens K, Vanhelmont T, Van Leuven F, Zabrocki P.

Biochim Biophys Acta. 2008 Jul;1783(7):1381-95. doi: 10.1016/j.bbamcr.2008.01.020. Epub 2008 Feb 11. Review.

10.

Functional mitochondria are required for alpha-synuclein toxicity in aging yeast.

Büttner S, Bitto A, Ring J, Augsten M, Zabrocki P, Eisenberg T, Jungwirth H, Hutter S, Carmona-Gutierrez D, Kroemer G, Winderickx J, Madeo F.

J Biol Chem. 2008 Mar 21;283(12):7554-60. doi: 10.1074/jbc.M708477200. Epub 2008 Jan 11.

11.

A yeast-based model of alpha-synucleinopathy identifies compounds with therapeutic potential.

Griffioen G, Duhamel H, Van Damme N, Pellens K, Zabrocki P, Pannecouque C, van Leuven F, Winderickx J, Wera S.

Biochim Biophys Acta. 2006 Mar;1762(3):312-8. Epub 2005 Dec 27.

12.

Characterization of alpha-synuclein aggregation and synergistic toxicity with protein tau in yeast.

Zabrocki P, Pellens K, Vanhelmont T, Vandebroek T, Griffioen G, Wera S, Van Leuven F, Winderickx J.

FEBS J. 2005 Mar;272(6):1386-400.

13.

The Saccharomyces cerevisiae type 2A protein phosphatase Pph22p is biochemically different from mammalian PP2A.

Zabrocki P, Swiatek W, Sugajska E, Thevelein JM, Wera S, Zolnierowicz S.

Eur J Biochem. 2002 Jul;269(14):3372-82.

14.

Protein phosphatase 2A on track for nutrient-induced signalling in yeast.

Zabrocki P, Van Hoof C, Goris J, Thevelein JM, Winderickx J, Wera S.

Mol Microbiol. 2002 Feb;43(4):835-42. Review.

15.

Multiple effects of protein phosphatase 2A on nutrient-induced signalling in the yeast Saccharomyces cerevisiae.

Sugajska E, Swiatek W, Zabrocki P, Geyskens I, Thevelein JM, Zolnierowicz S, Wera S.

Mol Microbiol. 2001 May;40(4):1020-6.

Supplemental Content

Loading ...
Support Center